M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Collegium Pharmaceutical, Inc to acquire Ironshore Therapeutics
Announced Sep 4, 2024 · Closed Sep 4, 2024 · Private target
Deal value$525M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Collegium Pharmaceutical, Inc (COLL)
- Target
- Ironshore Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Sep 4, 2024
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations